思创医惠2024年减亏明显 国资赋能推动业务转型与战略聚焦

Group 1 - The core viewpoint of the news is that Sichuang Medical has reported significant losses in 2024 but is actively transforming its business model to improve its financial situation and operational performance [1][2] - In 2024, Sichuang Medical's operating revenue was 691 million yuan, with a net loss attributable to shareholders of 502 million yuan, a reduction in losses by 42.64% year-on-year [1] - The company reported a net profit loss of 442 million yuan after excluding non-recurring items, which is a 50.88% reduction in losses compared to the previous year [1] Group 2 - Sichuang Medical has officially initiated the complete divestiture of its smart medical business to optimize its business structure and focus on its core operations [2] - The company aims to enhance its financial status and performance metrics through this strategic adjustment, which is expected to improve asset quality and profitability [2] - The focus will shift to the Internet of Things (IoT) sector, leveraging its strong technical foundation and practical experience in commercial intelligence [2] Group 3 - Sichuang Medical's products are exported to over 70 countries and regions, showcasing its strong international competitiveness and positive global market reputation [3] - The company has established long-term stable partnerships with over 300 global clients and agents, promoting the development of the commercial intelligence sector [3] - The establishment of the Cangnan IoT application production base marks a new phase in the company's strategic transformation and industrial upgrade [3] Group 4 - The entry of Cangnan State-owned Assets has provided new opportunities for Sichuang Medical, integrating the company's strategy with local industrial development [4] - A strategic cooperation agreement has been signed between Cangnan County Government and Sichuang Medical, focusing on four core areas: industrial integration, talent development, financial support, and capital cooperation [4] - This partnership is expected to ensure the stable operation of Sichuang Medical and promote sustainable development in the commercial intelligence market [4]